Amedisys Inc (AMED) FinancialsAMEDFinancialAmedisys Inc

Amedisys Inc (AMED) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Home Health Care, accounting for 63.7% of total sales, equivalent to $396.20M. Other significant revenue streams include Hospice and High Acuity Care. Understanding this composition is critical for investors evaluating how AMED navigates market cycles within the Healthcare Facilities & Services industry.

Evaluating the bottom line, Amedisys Inc maintains a gross margin of 43.26%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 11.70%, while the net margin is 4.67%. These profitability ratios, combined with a Return on Equity (ROE) of 7.26%, provide a clear picture of how effectively AMED converts its operational activities into shareholder value.

In the context of the broader market, AMED competes directly with industry leaders such as WGS and CON. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, AMED's gross margin of 43.26% stands against WGS's 68.37% and CON's 28.41%. Such benchmarking helps identify whether Amedisys Inc is trading at a premium or discount relative to its financial performance.